Propeller Health and Boehringer Ingelheim Collaborate on COPD, Asthma Tools for Better Health – COPD News Today


Drug Discovery & Development

Propeller Health and Boehringer Ingelheim Collaborate on COPD, Asthma Tools for Better Health
COPD News Today
Boehringer Ingelheim Pharmaceuticals and Propeller Health are partnering to use digital health tools and services to help patients with asthma and chronic obstructive pulmonary disease (COPD) to better cope with their condition. Under the terms of the …
FDA Approves Supplemental New Drug Application (sNDA) for Boehringer Ingelheim's STIOLTO RESPIMAT for COPD PR Newswire (press release)
Boehringer Ingelheim Enters Commercial Partnership with Propeller HealthPharmaceutical Technology Magazine (press release) (blog)

all 3 news articles »

View full post on asthma – Google News

Reduce asthma risks in 2016 winter season, shingles , COPD and bronchitis – Bel Marra Health

Reduce asthma risks in 2016 winter season, shingles , COPD and bronchitis
Bel Marra Health
Respiratory diseases like asthma, COPD and bronchitis can be troublesome in the winter season as the colder air can make it much more difficult to manage these diseases. Asthma in the winter can trigger asthma attacks and seasonal allergies. The cold …

View full post on asthma – Google News

Characteristics of reversible and nonreversible COPD and asthma and COPD … – Dove Medical Press

Characteristics of reversible and nonreversible COPD and asthma and COPD
Dove Medical Press
Abstract: The choice of inhaler device for bronchodilator reversibility is crucial since suboptimal inhalation technique may influence the result. On the other hand, bronchodilator response also varies from time to time and may depend on patient

View full post on asthma – Google News